# US 2023/0272186 A1 · Cure accelerators for anaerobic curable compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0272186 A1
- Document ID: US20230272186A1
- Status: Published application
- Kind: A1
- Application number: 18/112,046
- Filed: 2023-02-21
- Published: 2023-08-31
- Earliest claimed: 2020-08-18
- Assignees: Henkel AG & Co. KGaA
- Applicants: Henkel AG & Co. KGaA
- Inventors: Brian Deegan; Brendan Kneafsey; Nigel Sweeney; Patrick O'Dwyer; Stephen Fearon; Gavin Haberlin; David Birkett; David Condron; Marc Hamm; Vincent O'Brien
- Web page: https://patentgrep.com/patent/US20230272186A1

## CPC

- C08K 5/3437: condensed with carbocyclic rings
- C09J 4/00: Adhesives based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond {; adhesives, based on monomers of macromolecular compounds of groups C09J183/00 - C09J183/16}
- C08F 222/102: {of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate}
- C08F 265/06: Polymerisation of acrylate or methacrylate esters on to polymers thereof
- C09J 4/06: {Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond} in combination with a macromolecular compound other than an unsaturated polymer of groups C09J159/00 - C09J187/00
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- C09J: ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES (preparation of glue or gelatine C09H)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS

## Abstract

The present invention relates to cure accelerators useful for anaerobic curable compositions, such as adhesives and sealants. The cure accelerators may be embraced generally within the structure below where X is CH2, O, S, NR′, CR″R′″ or C═O; R is hydrogen or (meth)acryl; R6 is hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; and A and A1 are each individually selected from hydrogen or taken together create a ring structure of 5 to 12 total ring atoms, wherein the ring structure may be cycloaliphatic, cycloheteroaliphatic or aromatic or combinations thereof with or without substitution by one or more hydroxyl or (meth)acryl groups; and n is 0 or 1, provided that when R is hydrogen, A and A′ cannot both be hydrogen or taken together cannot be naphthyl.

## Claims

### Claim 1

An anaerobic curable composition comprising:
(a) a (meth)acrylate component;
(b) an anaerobic cure-inducing composition; and
(c) a cure accelerator embraced by structure I below:
wherein X is CH2, O, S, NR′, CR″ R′″ or C═O; R is hydrogen or (meth)acryl; R6 is hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; R′ is hydrogen or CHR″R′″, where R″ and R′″ are each individually selected from hydrogen, halogen, amino, carboxyl; nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; and A and A1 are each individually selected from hydrogen or taken together create a ring structure of 5 to 12 total ring atoms, wherein the ring structure may be cycloaliphatic, cycloheteroaliphatic or aromatic or combinations thereof with or without substitution by one or more hydroxyl or (meth)acryl groups; and n is 0 or 1, provided that when R is hydrogen, A and A′ cannot both be hydrogen or taken together cannot be naphthyl.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the cure accelerator is embraced by structure Ii below:
wherein X is CH2, O, S, NR10, CR8R9 or C═O; R is hydrogen or (meth)acryl; R1-R6 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl, or R1 and R2, R2 and R3, or R3 and R4 taken together form a carbocyclic ring of 5 to 7 ring members, where one or more of the ring members may be O, S or NR10; R10 is hydrogen or CHR8R9, where R8 and R9 are each individually selected from hydrogen, halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; Z is optionally present but when present is halogen, amino, carboxyl, nitro, alkyl, alkenyl, alkynyl, hydroxyalkyl, hydroxyalkenyl, hydroxyalkynyl, or alkaryl; and n is 0 or 1.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the cure accelerator is selected from the group consisting of
wherein A and A′, X and n are as defined above.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the cure accelerator is
wherein R and R′ are independent of one another but are as defined above for R, Z is as defined above and Y is NH.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the cure accelerator is
